Related by context. All words. (Click for frequent words.) 66 bronchoalveolar lavage 65 HSCT 64 allogeneic transplant 64 AST ALT 64 haematological 63 bacteremic 63 haematologic 63 hepatorenal syndrome 63 immunosuppression therapy 63 renal biopsy 63 Dacogen decitabine 62 pelvic ultrasound 62 myocardial revascularization 62 percutaneous vertebroplasty 62 posttransplant 62 liposomal amphotericin B 62 bone scintigraphy 62 percutaneous drainage 62 pretransplant 62 antibiotic regimens 62 epoetin alpha 62 genotypic resistance 62 bovine thrombin 61 epidural steroid injection 61 liver biopsies 61 histopathologic examination 61 hematologic parameters 61 cytologic 61 histopathological examination 61 enterococcal 61 metastatic malignant 61 metaplasia 61 endometrial biopsy 61 nodal metastasis 61 leukocytosis 61 macrolide antibiotic 61 parasitological 61 paracentesis 60 randomized controlled trials RCTs 60 Histopathological 60 HBV infections 60 antiangiogenic therapy 60 gastric adenocarcinoma 60 aminotransferase 60 bronchoalveolar lavage BAL 60 FDG PET imaging 60 seropositivity 60 Histological 60 needle aspiration 60 lung resection 60 anagrelide 60 TURBT 60 HIPEC 60 candidemia 60 thymectomy 60 genomic biomarker 60 atrioventricular block 60 pulmonary resection 60 lavage fluid 60 mediastinitis 60 perioperatively 60 malignant ascites 60 pouchitis 60 papillary renal cell carcinoma 60 pharmacodynamic parameters 60 glomerular filtration 60 busulfan 60 adjuvant radiotherapy 60 debulking surgery 60 ara C 60 lung biopsy 60 cardiac perfusion 60 cerebral angiography 59 molecular diagnostic assay 59 acupoint stimulation 59 monoinfected patients 59 postoperative infection 59 F FDG PET 59 cardiac revascularization 59 β blockers 59 oncological outcomes 59 pathologic examination 59 Bacteremia 59 scintigraphic 59 pT3 59 pleural fluid 59 clinico pathological 59 causative pathogen 59 liver metastasis 59 chemoradiation therapy 59 postoperative complication 59 postexposure prophylaxis 59 enzymatic assay 59 postsurgery 59 NATRECOR ® 59 caspofungin 59 Meta analyzes 59 VP# [004] 59 autologous SCT 59 intra abdominal infections 59 capsular polysaccharide 59 E. faecalis 59 endoscopic examinations 59 gonococcal 59 aortic root replacement 59 colonoscopic 59 metastatic malignant melanoma 59 EBUS FNA 59 carcinoid tumors 59 preoperative evaluation 59 thrombocytopenic 59 stem cell transplantations 59 intratympanic 59 hematologic abnormalities 59 preoperative diagnosis 59 urine dipstick 59 immunohistochemical analysis 59 intravesical therapy 59 serological tests 59 Hurthle cell 59 micafungin 59 riociguat 59 genitourinary cancers 59 pelvic lymphadenectomy 59 serologic tests 59 prospective multicenter study 58 immunomodulation 58 rtPA 58 oral anticoagulant therapy 58 transabdominal 58 sacral neuromodulation 58 T1c 58 pamidronate 58 bFGF 58 upper gastrointestinal endoscopy 58 hMG 58 tumorigenicity 58 extrapulmonary 58 cranial irradiation 58 murine models 58 MDCT scans 58 metastatic lymph nodes 58 radioiodine therapy 58 MYCAMINE 58 preclinical pharmacokinetic 58 histopathological 58 urography 58 relapsed ALL 58 pacemaker implantation 58 hepatectomy 58 cytological 58 phototoxicity 58 inotropic 58 FluCAM arm 58 thrombotic thrombocytopenic purpura TTP 58 HER2 expression 58 transrectal ultrasound guided 58 surgically resectable 58 ALA PDT 58 abdominal hysterectomy 58 inotropes 58 Candida infection 58 S aureus 58 postoperative chemotherapy 58 galiximab 58 nosocomial pneumonia 58 Histologic 58 LVNC 58 cytoreduction 58 SLNB 58 C. trachomatis 58 cTnI 58 intraperitoneal chemotherapy 58 urothelial cancer 58 papillary carcinoma 58 lymphocytosis 58 conventional angiography 58 reintubation 58 vasopressor 58 histological subtype 58 prostate carcinoma 58 autoimmune hemolytic anemia 58 immunosuppressive regimen 58 colorectal adenocarcinoma 58 LCP Tacro TM 58 vascular insufficiency 58 null responder 58 A. phagocytophilum 58 IPAH 58 Immunohistochemical staining 57 undergoing liver transplantation 57 D dimer 57 metastatic neuroendocrine tumors 57 bacillus Calmette Guerin 57 antibiotic prophylaxis 57 serologic 57 hemoglobin hematocrit 57 hemodilution 57 sonographic examinations 57 nephrotoxicity 57 G CSFs 57 keratoplasty 57 subcutaneous immunoglobulin 57 leiomyomas 57 transthoracic 57 hyperoxaluria 57 obscure gastrointestinal bleeding 57 HER2 amplification 57 prognostic variables 57 Allogeneic 57 immunostaining 57 retransplantation 57 erythropoietic 57 penicillin allergy 57 immunocompetent 57 allogeneic HSCT 57 renal transplants 57 preoperative chemotherapy 57 urine cytology 57 argatroban 57 hemolytic 57 elevated transaminases 57 histopathologic 57 Cerebrospinal fluid 57 cytogenic 57 urothelial carcinoma 57 etiologic 57 IGRAs 57 pathologic diagnosis 57 invasive carcinomas 57 empiric therapy 57 elective PCI 57 dosimetric 57 Lymph node 57 rebleeding 57 invasive candidiasis 57 Liver transplantation 57 renoprotective 57 endometrial biopsies 57 ALT flares 57 methotrexate therapy 57 syndromic 57 intracranial hemorrhage ICH 57 CsA 57 reoperations 57 pT2 57 Hypotension 57 alemtuzumab MS 57 ß blockers 57 undetectable HBV DNA 57 TPMT 57 extramedullary 57 Heavy menstrual bleeding 57 antimicrobial prophylaxis 57 total abdominal hysterectomy 57 SLN biopsy 57 operable breast cancer 57 thalidomide Thalomid 57 esophageal carcinoma 57 neutropenic 57 ciclosporin 57 trastuzumab Herceptin ® 57 transcriptomic 57 thromboprophylaxis 57 thymoma 57 primary hyperparathyroidism 57 electrophysiologic 57 maternal serum 57 antiphospholipid antibodies 57 Helicobacter pylori eradication 57 preoperative MRI 57 clevidipine 57 thoracentesis 57 mitomycin C 57 mycophenolate mofetil MMF 57 corticosteroid therapy 57 rFVIIa 57 benign prostatic hypertrophy BPH 57 squamous intraepithelial lesions 57 ASCUS 57 lesional 57 methotrexate monotherapy 57 leukocyte count 57 somatostatin analogs 57 #F FDG PET 57 ultrasonographic examination 57 pancreatic resection 57 renal tumors 57 AGHD 57 radioimmunotherapy RIT 57 pelvic lymph node dissection 57 immunosuppressive therapies 57 tuberculin test 57 pituitary hormone 57 esophageal candidiasis 57 colony stimulating factors 57 lenalidomide dexamethasone 57 epithelial tumors 57 ELISPOT 57 FXIII 56 antithrombotic therapy 56 rFSH 56 bronchogenic carcinoma 56 esophagogastric 56 urodynamic 56 immunomodulatory agents 56 invasive aspergillosis 56 pulmonary artery banding 56 vasoactive 56 antimicrobial susceptibility testing 56 carcinoids 56 transvaginal sonography 56 interstitial brachytherapy 56 esophagogastroduodenoscopy 56 Lucentis ranibizumab Genentech 56 postsurgical 56 surgical revascularization 56 prognostic indicators 56 intravenous immunoglobulin 56 PNH patients 56 Troponin T 56 lymphocyte count 56 iodixanol 56 vaginal hysterectomy 56 node dissection 56 histologic examination 56 demyelinating 56 intravenous immunoglobulin IVIG 56 humoral responses 56 microsatellite instability 56 dose cohort 56 Tc#m 56 hemodynamically stable 56 unresectable tumors 56 non selective NSAIDs 56 prostate cancer CaP 56 liver biopsy 56 Humate P 56 thorough QT 56 Aspergillus nidulans 56 lupus anticoagulant 56 undetectable hepatitis C 56 cervical carcinoma 56 differential gene expression 56 concurrent chemoradiation 56 gastric carcinoma 56 LHRH agonists 56 tumoral 56 solar keratoses 56 cytoreductive surgery 56 ER CHOP 56 warfarin dosage 56 florbetaben 56 Retreatment 56 Histopathologic examination 56 saline infusion 56 MGd 56 GAMMAGARD 56 LEUKINE 56 creatine kinase CK 56 histologic subtype 56 abacavir Ziagen 56 pain palliation 56 steroid refractory 56 postoperative radiotherapy 56 neutrophil counts 56 ImmuKnow 56 liver resection 56 Microarray analysis 56 stool specimens 56 Cepheid Xpert 56 AMEVIVE 56 doxorubicin docetaxel 56 allogeneic hematopoietic stem cell 56 hepatocellular carcinomas 56 cystoscopic 56 immunochemical fecal occult 56 amoxicillin clavulanate 56 immunosuppressant therapy 56 clinicopathological 56 porcine derived 56 transrectal ultrasound 56 CA9 SCAN 56 hypotensive 56 intraperitoneally 56 bacteraemia 56 viremic 56 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 56 superficial basal cell carcinoma 56 verteporfin 56 endophthalmitis 56 gynaecologic 56 Alphanate R 56 SSTIs 56 portal vein thrombosis 56 ICD shocks 56 HIV HCV coinfected 56 IOP lowering 56 procedural sedation 56 pharmacologic stress 56 acetaminophen toxicity 56 cranial radiation 56 intravitreal triamcinolone 56 renal allograft 56 T1a 56 intravenous bisphosphonates 56 aspartate aminotransferase AST 56 postexposure 56 ano genital warts 56 trypsin digestion 56 sonographic examination 56 diagnostic laparoscopy 56 Immunotherapeutic 56 Xelox 56 thyroid carcinoma 56 herpetic keratitis 56 pentostatin 56 latent celiac disease 56 Doxil ® 56 immunohistochemical staining 56 recurrent glioblastoma multiforme 56 voiding dysfunction 56 immunohistochemical 56 intravenous tPA 56 anogenital warts 56 troponins 56 viral reactivation 56 multivariable analyzes 56 euthyroid 56 fluvastatin 56 tumor lysis syndrome 56 urethral stricture 56 histologically proven 56 viral kinetics 56 calcineurin inhibitors 56 immunosuppressive agents 56 Lp PLA 2 55 antibody titer 55 colorectal liver metastases 55 neutropenic patients 55 Skin sterol 55 pulmonary angiography 55 intranasal corticosteroids 55 trophoblast cells 55 prospectively enrolled 55 Serum creatinine 55 tigecycline 55 microbiologic 55 D Dimer 55 aneuploidy screening 55 TMP SMX 55 GH deficiency 55 warfarin therapy 55 NSABP B 55 platelet inhibitor 55 BrachySil TM 55 chemoembolization 55 BACcel 55 prostate cancer PCa 55 lymphatic vessel 55 aspartate aminotransferase 55 mycobacterial 55 HCV antibody 55 LV ejection fraction 55 BALF 55 concomitant antibiotics 55 relapsed MM 55 somatostatin analogues 55 gonococcal infections 55 histologic diagnosis 55 adjuvant therapies 55 renal cell carcinomas 55 intracerebral haemorrhage 55 histocompatibility 55 cynomolgus monkeys 55 anti androgens 55 intraabdominal 55 quinolone antibiotics 55 von Willebrand 55 bladder carcinoma 55 neuropathologic 55 mycophenolate 55 neoadjuvant therapy 55 liver transplant recipients 55 rt PA 55 BEXXAR Therapeutic Regimen 55 Mantoux test 55 VATS lobectomy 55 OPCAB 55 CHAMPION PCI 55 myeloproliferative disorders 55 recurrent UTI 55 intracavitary 55 VTE prophylaxis 55 Acute renal failure 55 nephrogenic 55 Coronary Artery Bypass Graft 55 SSc 55 HBeAg negative 55 cytopenias 55 multicenter randomized controlled 55 MYLOTARG 55 tissue oxygenation 55 GHRH 55 severe neutropenia 55 ovarian hyperstimulation 55 cytoreductive nephrectomy 55 supernatants 55 metastatic uveal melanoma 55 Multivariate logistic regression 55 cytotoxicity assays 55 DVT prophylaxis 55 demonstrated antitumor activity 55 pyridostigmine 55 intralesional 55 crossclamp 55 neutrophil count 55 Intravenous Infusion 55 Avastin bevacizumab Genentech 55 hematological parameters 55 immune globulins 55 biologic DMARD 55 ultrasonographic 55 Histopathologic 55 transurethral 55 egg retrieval 55 Elitek 55 pheochromocytoma 55 PCI ExTRACT TIMI 55 cutaneous melanoma 55 eosinophilic pneumonia 55 radical cystectomy 55 flavopiridol 55 G6PD deficiency 55 total thyroidectomy 55 arteriovenous fistulas 55 resected tumors 55 immunosuppressives 55 intestinal metaplasia 55 dose titration 55 therapeutic regimens 55 haematopoietic stem cell 55 fallopian tube cancers 55 cervicitis 55 SIR Spheres 55 OvaRex MAb 55 hepatic toxicity 55 GRNCM1 55 bypass grafting 55 symptomatic carotid stenosis 55 SYN# 55 mucinous 55 Cimzia TM 55 MAGE A3 ASCI 55 enucleation 55 radiotherapy RT 55 lactate dehydrogenase LDH 55 transplantation HSCT 55 Natalizumab 55 Western blotting 55 recombinant interferon 55 mcg doses 55 Adenomas 55 PEG IFN 55 myocardial necrosis 55 developmental neurotoxicity 55 neoadjuvant treatment 55 S. maltophilia 55 rBChE 55 adenomatous 55 hibernating myocardium 55 aromatase inhibitor therapy 55 biodistribution studies 55 HIV coinfected 55 PCWP 55 Infusion Reactions Severe 55 bone marrow biopsies 55 immuno compromised patients 55 liposome formulation 55 thymidine kinase 55 vismodegib 55 tolevamer 55 cervical lymph nodes 55 Platinol ® 55 tonsillar hypertrophy 55 clinicopathological features 55 multiorgan 55 chronic GVHD 55 reinfusion 55 Navelbine ® 55 reimplantation 55 methylation biomarkers 55 lymphadenectomy 55 interferon lozenges 55 pharmacodynamic PD 55 G#DT 55 extrapleural pneumonectomy 55 androgen ablation 55 gastroduodenal 55 CIMZIA TM certolizumab pegol 55 grade squamous intraepithelial 55 Evaluable 55 osteoid osteoma 55 HCV replicon 55 intravenous immunoglobulin IVIg 55 endobronchial 55 bronchoalveolar lavage fluid 55 myopathy rhabdomyolysis 55 nephrectomy 55 skeletal metastases 55 RBC transfusions 55 Diastolic Heart Failure 55 Vidaza azacitidine 55 alanine aminotransferase ALT 55 empiric treatment 55 perfusion CT 55 GIST tumors 55 clinicopathologic 55 p# biomarker 55 transfusion transmitted 55 beta interferons 55 thromboembolic disease 55 LVRS 55 vitro experiments 55 cytogenetic abnormalities 55 Alequel 55 Radical prostatectomy 55 Adjuvant therapy 55 antiplatelet therapies 55 BSIs 55 neonatal sepsis 54 intestinal permeability 54 LRTI 54 certolizumab 54 Chronic Prostatitis 54 intradermal injections 54 Pneumocystis carinii pneumonia 54 serological 54 nodal dissection 54 BPS IC 54 imipenem 54 PSA nadir 54 lymph node dissection 54 pulmonary artery catheterization 54 Confirmatory 54 oral anticoagulation 54 Flow cytometry 54 invasive lobular carcinoma 54 GnRH agonists 54 peritoneal carcinomatosis 54 hematological relapse 54 extubation 54 granulocyte 54 efalizumab 54 bortezomib Velcade 54 allogeneic transplants 54 cervical cytology 54 ASSERT trial 54 recombinant enzyme 54 Phase IIb clinical trials 54 sputum smear 54 hematological adverse 54 proton MR spectroscopy 54 histologically confirmed 54 bronchial epithelial cells 54 Immunohistochemical analysis 54 metabolite concentrations 54 stem cell engraftment 54 BETAS 54 antiresorptive 54 renal transplantation 54 phase IIIb 54 adverse cytogenetics 54 IV NSCLC 54 thrombotic complications 54 vidofludimus 54 Cardiotoxicity 54 intratumoral 54 serological testing 54 biochemical relapse 54 edifoligide E2F Decoy 54 normal karyotype 54 multivariate regression analysis 54 Lymphoid 54 bolus dose 54 CYP #D# 54 myeloablative 54 SIADH 54 semiquantitative 54 intraperitoneal injection 54 injectable antibiotics 54 torsade de pointes 54 photodamaged skin 54 follicular thyroid cancer 54 PCSM 54 echocardiographic parameters 54 mutagenicity 54 smoldering myeloma 54 moderately emetogenic 54 isoenzyme 54 Trofex 54 administered intraperitoneally 54 metaanalysis 54 invasive carcinoma 54 HBeAg + 54 microdose 54 anti angiogenic agents 54 CINTREDEKIN BESUDOTOX 54 submucosal 54 papillary thyroid carcinoma 54 photodynamic treatment 54 Intravenous immunoglobulin 54 Trovax 54 chemoprevention trials 54 renal cysts 54 Actinic Keratosis 54 thyroglobulin 54 doxorubicin HCl 54 osteoporotic vertebral compression fractures 54 endotoxemia 54 malignant nodules 54 bacterial sepsis 54 peginterferon alpha 54 CIN2 + 54 benign neoplasms 54 endoscopic ultrasonography 54 Immunohistochemistry 54 candidiasis 54 mitochondrial toxicity 54 proliferative disorders 54 pulmonary toxicity 54 TKI therapy 54 cidofovir 54 biliary tract cancer 54 dose melphalan 54 ClearPath HDR 54 Fully Covered Stent 54 Elevated serum 54 lymphomas leukemias 54 tumor necrosis 54 AFRS TM 54 Histopathology 54 lenalidomide Revlimid 54 transcranial Doppler ultrasound 54 Venous thromboembolism 54 steroidogenic 54 sacral nerve stimulation 54 choriocarcinoma 54 renal artery stenting 54 azacytidine 54 #ß 54 HGPIN 54 chemoradiotherapy 54 computed tomographic scan 54 adjuvant cisplatin 54 immunocompetent patients 54 fasting plasma 54 CRRT 54 adjuvant tamoxifen 54 TKAs 54 recombinant FSH 54 BoNTA 54 interferon γ 54 HBsAg 54 polycythemia vera essential thrombocythemia 54 drug eluting stent implantation 54 diagnostic biomarker 54 undergoing peritoneal dialysis 54 mesenteric 54 Surgical resection 54 weekly subcutaneous injections 54 acute myocarditis 54 ATIR 54 hypersensitivity allergic reactions 54 daily subcutaneous injections 54 antiemetics 54 mycosis fungoides 54 PPCM 54 chronic thromboembolic pulmonary 54 TMPRSS2 ERG 54 Serologic 54 postoperative hemorrhage 54 immunosuppressive regimens 54 alefacept 54 radical nephrectomy 54 Tigecycline 54 intravenous tissue plasminogen 54 anthracyclines taxanes 54 PTLD 54 TNF antagonist 54 Rh factor 54 systemic corticosteroid 54 transgenic rats 54 pegylated interferon alfa 54 ovarian malignancy 54 laparoscopic radical nephrectomy 54 ergot alkaloids 54 methylprednisolone 54 transthoracic echocardiography 54 N. gonorrhoeae 54 multicenter clinical trials 54 tipranavir ritonavir 54 squamous cell carcinoma SCC 54 Pegylated Liposomal Doxorubicin 54 Vectibix monotherapy 54 intravenous vancomycin 54 5-fluorouracil/leucovorin 54 nephrotoxic drugs 54 renal transplant 54 lenalidomide Revlimid R 54 autologous hematopoietic stem cell 54 unfavorable cytogenetics 54 MDCT angiography 54 Hematologic 54 meniscectomy 54 Phase IIIb study 54 corticosteroid dexamethasone 54 murine model 54 interobserver 54 divalproex sodium 54 revision hip arthroplasty 54 alpha 2a 54 antiangiogenic agent 54 underwent resection 54 AA Amyloidosis 54 colorectal cancer liver metastases 54 ganciclovir 54 Multivariate analysis 54 PEARL SC 54 humanised monoclonal antibody 54 mycophenolate mofetil 54 PROLARIS 54 resected pancreatic cancer 54 gemtuzumab ozogamicin 54 db db mice 54 GnRH agonist 53 breast carcinoma 53 gastric corpus 53 Estrogen Receptor 53 intra arterial chemotherapy 53 teratogenicity 53 benign uterine 53 epithelial barrier 53 vascularisation 53 OHR/AVR# 53 mechanistic studies 53 sipuleucel T 53 leucocyte 53 intravenous diuretics 53 ovarian carcinoma 53 intravesical 53 hypoperfusion 53 extracranial 53 immunosuppressed patients 53 computed tomographic scans 53 Patency 53 Certolizumab pegol 53 oocyte retrieval 53 Fontan procedure 53 ESBLs 53 stool specimen 53 surgically resected 53 EGFRIs 53 imexon 53 Adjuvant chemotherapy 53 cerebrospinal fluid CSF 53 locoregional 53 radiolabeled TM# 53 MENOPUR ® 53 UPLYSO 53 etanercept Enbrel 53 neoadjuvant setting 53 dorsal root ganglion 53 Cloretazine 53 IMPACT DCM 53 novel immunotherapeutic 53 antiangiogenic drugs 53 PSMA ADC 53 prostate adenocarcinoma 53 vesicoureteral reflux VUR 53 serum calcium levels 53 TLK# 53 immunotoxicity 53 histopathology 53 prevent reinfection 53 TRUS biopsy 53 prospectively stratified 53 diagnostic workup 53 Squamous 53 kidney allograft 53 coexisting illnesses 53 guideline concordant 53 myeloperoxidase 53 intravenous dosing 53 ribavirin therapy 53 Randomized controlled 53 mutated K ras 53 uterine fibroid 53 nonsmall cell lung cancer 53 dose escalation phase 53 localized renal 53 CLL SLL 53 choroidal vasculopathy 53 bronchoscopies 53 transgene expression 53 perioperative mortality 53 Factor VIIa 53 myomas 53 pancreatic adenocarcinoma 53 gastrointestinal stromal tumors GISTs 53 Velcade bortezomib 53 longitudinal observational study 53 Kamada AAT 53 nitroprusside 53 Bacillus Calmette Guerin BCG 53 #F FDG 53 cytomegalovirus infection 53 pretreatment serum 53 imatinib therapy 53 pharmacodynamic endpoints 53 myelodysplastic myeloproliferative diseases 53 OrCel 53 endoscopist 53 extracapsular extension 53 NRTI resistance 53 Pemetrexed 53 Buhimschi 53 myeloproliferative diseases 53 urocortin 2 53 Intra arterial 53 hypofractionated radiation 53 Pseudomonas aeruginosa infections 53 SCIg 53 sonographically 53 Talotrexin 53 antiarrhythmic drug 53 EuroSCORE 53 adnexal mass 53 intraperitoneal therapy 53 coagulation disorders 53 IVIG therapy 53 gefitinib Iressa 53 hereditary deficiency 53 Photodynamic therapy 53 polidocanol 53 decompensated cirrhosis 53 chronic hemodialysis 53 enzyme immunoassay EIA 53 NOD SCID mice 53 prucalopride 53 hepatic encephalopathy HE 53 platelet transfusions 53 eosinophilic asthma 53 NIHSS score 53 PSGs 53 beam radiotherapy 53 allogenic 53 ZOMETA 53 RECIST Response Evaluation Criteria 53 neoadjuvant chemoradiotherapy 53 venous stasis ulcers 53 allogeneic transplantation 53 Cloretazine VNP#M 53 intraoperative ultrasound 53 external beam radiotherapy 53 SSc patients 53 presurgical 53 seminal vesicle 53 bone marrow aspiration 53 decubitus ulcers 53 Immune Globulin 53 alpha1 antitrypsin deficiency 53 Allovectin 7 ® 53 DSM IV diagnoses 53 epidural steroid injections 53 PD2i ® 53 Hemodynamic 53 aldosterone antagonist 53 mediated inhibition 53 myelomas 53 FDG PET scan 53 ARCOXIA 53 frameless radiosurgery 53 tipranavir r 53 cryptococcal meningitis 53 meta analysis pooling 53 randomized multicenter trial 53 RAS mutations 53 Onconase 53 cerebral vasospasm 53 antithymocyte globulin 53 prospective nonrandomized 53 Endometrial 53 intermittent hemodialysis 53 graft dysfunction 53 cystectomy 53 allogeneic hematopoietic cell 53 postoperative pulmonary 53 VCUG